Lv35
398 积分 2024-06-11 加入
Structural Basis of AZD9291 Selectivity for EGFR T790M
2天前
已完结
Every Patient Is Unique and Deserves the Best: The Present and Future Treatment Landscape of Uncommon Epidermal Growth Factor Receptor Mutations in Non–Small Cell Lung Cancer
2天前
已关闭
Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study
3天前
已完结
Progress in the treatment of pulmonary metastases after liver transplantation for hepatocellular carcinoma
4天前
已完结
Sorafenib in combination with transarterial chemoembolization and bronchial arterial chemoinfusion in the treatment of hepatocellular carcinoma with pulmonary metastasis
4天前
已完结
[Retrospective analysis of clinical results in eight patients with advanced hepatocellular carcinoma with lung metastases treated by TS-1]
4天前
已关闭
Prevalence, management and outcomes of pulmonary metastases in hepatocellular carcinoma: a systematic review and meta-analysis
4天前
已关闭
Clinical outcomes of systemic chemotherapy in hepatocellular carcinoma patients with multiple lung metastases
4天前
已完结
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
5天前
已完结
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib
5天前
已完结
皖公网安备34019202002308
